These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1695827)

  • 21. Altered androgen metabolism in metastatic prostate cancer.
    Kliman B; Prout GR; Maclaughlin RA; Daly JJ; Griffin PP
    J Urol; 1978 May; 119(5):623-6. PubMed ID: 77915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolism and action of steroid hormones on human benign prostatic hyperplasia and prostatic carcinoma grown in organ culture.
    Lasnitzki I
    J Steroid Biochem; 1979 Jul; 11(1B):625-30. PubMed ID: 90755
    [No Abstract]   [Full Text] [Related]  

  • 23. Testosterone metabolism by homogenates of human prostates with benign hyperplasia: effects of zinc, cadmium and other bivalent cations.
    Sinquin G; Morfin RF; Charles JF; Floch HH
    J Steroid Biochem; 1984 Mar; 20(3):773-80. PubMed ID: 6200704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Androgen dynamics in vitro in the normal and hyperplastic human prostate gland.
    Giorgi EP; Stewart JC; Grant JK; Scott R
    Biochem J; 1971 Jun; 123(1):41-55. PubMed ID: 4108500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct androgen 5 alpha-reduction pathways in cultured fibroblasts and immortalized epithelial cells from normal human adult prostate.
    Boudou P; Cussenot O; Sollman H; Villette JM; Teillac P; Le Duc A; Fiet J
    J Urol; 1994 Jul; 152(1):226-31. PubMed ID: 8201672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Metabolism of 3H-testosteron and 3H-5alpha-DHT in the normal and adenomatous prostate (author's transl)].
    Becker H; Klosterhalfen H; Voigt KD
    Urol Int; 1973; 28(3):350-5. PubMed ID: 4127746
    [No Abstract]   [Full Text] [Related]  

  • 27. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.
    Bartsch G; Rittmaster RS; Klocker H
    Eur Urol; 2000 Apr; 37(4):367-80. PubMed ID: 10765065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of megestrol acetate (Megace) on steroid metabolism and steroid-protein binding in the human prostate.
    Geller J; Albert J; Geller S; Lopez D; Cantor T; Yen S
    J Clin Endocrinol Metab; 1976 Nov; 43(5):1000-8. PubMed ID: 62759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Androgen metabolism in the prostate of the finasteride-treated, adult rat: a possible explanation for the differential action of testosterone and 5 alpha-dihydrotestosterone during development of the male urogenital tract.
    George FW
    Endocrinology; 1997 Mar; 138(3):871-7. PubMed ID: 9048585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [5 alpha-dihydrotestosterone and prostatic adenoma].
    Morfin R; Charles JF; Bercovici JP
    J Urol Nephrol (Paris); 1978; 84(10-11):691-703. PubMed ID: 84877
    [No Abstract]   [Full Text] [Related]  

  • 31. Dihydrotestosterone in prostatic hypertrophy. II. The formation and content of dihydrotestosterone in the hypertrophic canine prostate and the effect of dihydrotestosterone on prostate growth in the dog.
    Gloyna RE; Siiteri PK; Wilson JD
    J Clin Invest; 1970 Sep; 49(9):1746-53. PubMed ID: 4194769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Androgen dynamics in vitro in the human prostate gland. Effect of cyproterone and cyproterone acetate.
    Giorgi EP; Shirley IM; Grant JK; Stewart JC
    Biochem J; 1973 Mar; 132(3):465-74. PubMed ID: 4125095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered androgen metabolism in carcinoma of the prostate.
    Ghanadian R; Masters JR; Smith CB
    Eur Urol; 1981; 7(3):169-70. PubMed ID: 6162644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in dihydrotestosterone metabolism associated with the development of canine benign prostatic hyperplasia.
    Isaacs JT; Coffey DS
    Endocrinology; 1981 Feb; 108(2):445-53. PubMed ID: 6161001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of the cytosol androgen receptor of the human prostate.
    Wilbert DM; Griffin JE; Wilson JD
    J Clin Endocrinol Metab; 1983 Jan; 56(1):113-20. PubMed ID: 6183286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concentration of dihydrotestosterone and 3 alpha-androstanediol in naturally occurring and androgen-induced prostatic hyperplasia in the dog.
    Moore RJ; Gazak JM; Quebbeman JF; Wilson JD
    J Clin Invest; 1979 Oct; 64(4):1003-10. PubMed ID: 90055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intraprostatic testosterone and dihydrotestosterone. Part II: concentrations after androgen hormonal manipulation in men with benign prostatic hyperplasia and prostate cancer.
    van der Sluis TM; Meuleman EJ; van Moorselaar RJ; Bui HN; Blankenstein MA; Heijboer AC; Vis AN
    BJU Int; 2012 Jan; 109(2):183-8. PubMed ID: 21992404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pathogenesis of prostatic hyperplasia in normal and adenomatous glands of men and dogs: 3-alpha reduction of dihydrotestesterone].
    Jacob GH
    Endokrinologie; 1977 Oct; 70(2):158-68. PubMed ID: 73458
    [No Abstract]   [Full Text] [Related]  

  • 39. Prostatic growth: new insights into hormonal regulation.
    McConnell JD
    Br J Urol; 1995 Jul; 76 Suppl 1():5-10. PubMed ID: 7544215
    [No Abstract]   [Full Text] [Related]  

  • 40. [Androgens].
    Shida K; Ito Z; Yamanaka H
    Horumon To Rinsho; 1975 Dec; 23(12):1203-19. PubMed ID: 55321
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.